These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 31479159)
21. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents. Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A; Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798 [TBL] [Abstract][Full Text] [Related]
22. Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. Shaikh T; Handorf EA; Meyer JE; Hall MJ; Esnaola NF JAMA Oncol; 2018 Feb; 4(2):e173580. PubMed ID: 29121143 [TBL] [Abstract][Full Text] [Related]
23. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113 [TBL] [Abstract][Full Text] [Related]
24. Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors. Lee M; Eng G; Barbari SR; Deshpande V; Shcherbakova PV; Gala MK Clin Transl Gastroenterol; 2020 Mar; 11(3):e00149. PubMed ID: 32352724 [TBL] [Abstract][Full Text] [Related]
25. Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer. Mo S; Ma X; Li Y; Zhang L; Hou T; Han-Zhang H; Qian J; Cai S; Huang D; Peng J J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32859741 [TBL] [Abstract][Full Text] [Related]
26. Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population. Suzuki O; Eguchi H; Chika N; Sakimoto T; Ishibashi K; Kumamoto K; Tamaru JI; Tachikawa T; Akagi K; Arai T; Okazaki Y; Ishida H Surg Today; 2017 Sep; 47(9):1135-1146. PubMed ID: 28258479 [TBL] [Abstract][Full Text] [Related]
27. Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma. Goeppert B; Roessler S; Renner M; Singer S; Mehrabi A; Vogel MN; Pathil A; Czink E; Köhler B; Springfeld C; Pfeiffenberger J; Rupp C; Weiss KH; Schirmacher P; von Knebel Doeberitz M; Kloor M Br J Cancer; 2019 Jan; 120(1):109-114. PubMed ID: 30377340 [TBL] [Abstract][Full Text] [Related]
28. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654 [TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE gene. Hino H; Shiomi A; Kusuhara M; Kagawa H; Yamakawa Y; Hatakeyama K; Kawabata T; Oishi T; Urakami K; Nagashima T; Kinugasa Y; Yamaguchi K Cancer Med; 2019 Aug; 8(10):4587-4597. PubMed ID: 31240875 [TBL] [Abstract][Full Text] [Related]
30. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study. Domingo E; Freeman-Mills L; Rayner E; Glaire M; Briggs S; Vermeulen L; Fessler E; Medema JP; Boot A; Morreau H; van Wezel T; Liefers GJ; Lothe RA; Danielsen SA; Sveen A; Nesbakken A; Zlobec I; Lugli A; Koelzer VH; Berger MD; Castellví-Bel S; Muñoz J; ; de Bruyn M; Nijman HW; Novelli M; Lawson K; Oukrif D; Frangou E; Dutton P; Tejpar S; Delorenzi M; Kerr R; Kerr D; Tomlinson I; Church DN Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):207-216. PubMed ID: 28404093 [TBL] [Abstract][Full Text] [Related]
31. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer. Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779 [TBL] [Abstract][Full Text] [Related]
32. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy. Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873 [TBL] [Abstract][Full Text] [Related]
33. Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas. Nielsen M; de Miranda NF; van Puijenbroek M; Jordanova ES; Middeldorp A; van Wezel T; van Eijk R; Tops CM; Vasen HF; Hes FJ; Morreau H BMC Cancer; 2009 Jun; 9():184. PubMed ID: 19527492 [TBL] [Abstract][Full Text] [Related]
34. Tumor and Patient Characteristics of Individuals with Mismatch Repair Deficient Colorectal Cancer. Waldmann E; Ferlitsch M; Binder N; Sellner F; Karner J; Heinisch B; Klimpfinger M; Trauner M Digestion; 2015; 91(4):286-93. PubMed ID: 25924923 [TBL] [Abstract][Full Text] [Related]